Dr. Deppe (www.drdeppe.de) was established in 1980 and is a provider of disinfectant products that contribute substantially to hygiene and infection control in the healthcare sector. From development to production and filling, DrDeppe produces a comprehensive range of high-quality liquids, soaps, creams, gels, and soaked wipes. The disinfectants are certified, highly effective, and safe. DrDeppe has represented this for over 40 years with its development and manufacturing expertise, innovative ideas and disinfection know-how.
In 2017, INVISION acquired a majority stake in the company as part of a succession solution for the founding Deppe family. During the investment period, INVISION successfully facilitated the transition to the current managing directors, Dr. Mark Derks and Hendrik Hahn, and established a strategic direction for the future. Significant investments in the two Kempen facilities have considerably expanded production capacities and substantially enhanced the company’s regulatory expertise. This enabled Dr. Deppe to successfully obtain MDR certification (Regulation (EU) 2017/745 on medical devices). Furthermore, numerous approval procedures for biocide approvals were successfully completed. By obtaining the necessary certificates, DrDeppe is now able to supply its customers with medical devices that comply with the MDR, as well as to bring new innovations and product developments to the market.
Dr. Mark Derks, Managing Director of DrDeppe: “With its many years of experience, INVISION has helped us to successfully master the succession situation at DrDeppe. We have always experienced INVISION as a collaborative and entrepreneurial partner.”
Hendrik Hahn, Managing Director of DrDeppe, adds: “Thanks to the strategic decisions and investments, we are ideally equipped for the future. We still have a lot planned and see a lot of potential. We look forward to exploiting this potential together with our new shareholder.”
Florian Preuss from INVISION in Germany: “INVISION is pleased to have been a part of the company’s 44-year history and to have contributed to this success story. We would like to thank the managing directors Mark and Hendrik as well as all the highly committed employees in Kempen for the great cooperation over the past years.”
Oliver Nehring, Managing Director of Adeleon: “We are very pleased to welcome DrDeppe as a new member of our Adeleon family. Under the outstanding leadership of Dr. Mark Derks and Hendrik Hahn, DrDeppe has developed into one of the leading companies in the disinfectant industry”
The transaction has already been completed.
Invision Capital Partners V Ltd, acting in its capacity as General Partner for Invision V L.P, was advised by Invision Beteiligungsberatung GmbH and act legal.
About DrDeppe
Dr. Deppe is a leading supplier of professional disinfectants, cleaning products, and disinfectant wipes in Germany. The company, headquartered in Kempen, employs over 90 individuals and was established in 1980 by Dr. Hans Dieter Deppe. Since its founding, the company has experienced growth in both domestic and international markets. Its product sales are primarily focused on the B2B sector, with a majority of its customers being outpatient medical practices, dental practices, and care facilities.
For additional information please visit www.drdeppe.de.
About INVISION
Since its foundation in 1997, INVISION has become a leading mid-market private equity firm focused on entrepreneurial successions and growth buyouts in German-speaking regions. INVISION has invested in over 80 businesses and achieved sustainable value creation for its portfolio companies. INVISION seeks to adapt its deal structures and investment approach to fit the specific needs of the situation by developing customized solutions to address the respective needs of all stakeholders.
DrDeppe is an investment from the INVISION V L.P. fund.
For additional information please visit www.invision.ch.
About Adeleon
Adeleon is a medium-sized, family-run company based in Monheim am Rhein. The company’s management, capital, and family ties are closely interwoven. This synergy has been the foundation of the company’s economic success for nearly 78 years. The three founding families remain at the company’s core, influencing its culture and values since the founding in 1946. Currently, the company includes eight subsidiaries at nine locations in Europe with a combined workforce of over 400 employees.
For additional information please visit www.adeleon.de.
Contact
INVISION Beteiligungsberatung GmbH
Grünstrasse 23
40212 Düsseldorf
Tel: +49 211 936 727 50
info[at]invision.ch
